# How participants in clinical studies enable medical progress

The heroes behind medicine: how participants in clinical studies enable medical progress

## Drug discovery Boehringer Ingelheim

Every day, scientists at Boehringer Ingelheim embark on a journey. It is a journey that can take up to 15 years and requires significant investment. Only a tiny proportion of these journeys are successful.

## Pioneering New Medicines Through External Innovation

On 22 November 2024 Boehringer Ingelheim hosted the event “Unleashing Innovation at Boehringer Ingelheim: Pioneering New Medicines Through External Innovation” at the Institute of Molecular Pathology (IMP)

## Turning Point for Immunotherapy: Monocytes Strengthen T Cells

Immunotherapy boosts the immune system to fight cancer, but some tumors adapt and become resistant. The tumor’s microenvironment plays a complex role, sometimes blocking and sometimes aiding immune responses.

## Unlocking the ‘dark genome’ for cancer immunotherapy

Our scientists are driving the discovery of unexplored cancer antigens from the ‘dark genome’ to develop novel cancer immunotherapies.

## Partnering in Oncology AH JANUARY 2025 CORP

Provides a summary of Boehringer Ingelheim's animal health partnering interests in Oncology.

## Partnering in Immunology & Inflammation AH JANUARY 2025 CORP

Summary of Boehringer Ingelheim Animal Health partnering interests in Immunology & Inflammation.

---